| A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016) | Phase III | rekrutiert |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed | Phase III | rekrutiert |
| A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world Sett | — | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradi | Phase III | rekrutiert |
| A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic L | Phase III | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia | Phase I | rekrutiert |
| A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature | Phase II | rekrutiert |
| A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Throm | Phase III | rekrutiert |
| A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoc | Phase III | rekrutiert |
| A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH | Phase III | rekrutiert |
| A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NAS | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab a | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosi | Phase III | rekrutiert |
| A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Ce | Phase III | rekrutiert |
| A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With | — | rekrutiert |
| A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumita | Phase II | rekrutiert |
| A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell | Phase I / Phase II | rekrutiert |
| A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic | Phase III | rekrutiert |
| A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors | Phase I / Phase II | rekrutiert |
| A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With | Phase III | rekrutiert |
| A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months | Phase II | rekrutiert |
| A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Hu | Phase II | rekrutiert |
| A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder | Phase III | rekrutiert |
| A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refr | Phase I / Phase II | rekrutiert |
| A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Al | Phase III | rekrutiert |
| A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Aga | Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + | Phase III | rekrutiert |
| A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEP | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants Wit | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cir | Phase III | rekrutiert |
| A Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Ey | ohne Phasenangabe | rekrutiert |
| A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants | Phase I / Phase II | rekrutiert |
| A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenou | Phase III | rekrutiert |
| Abbott DBS Post-Market Study of Outcomes for Indications Over Time | — | rekrutiert |
| Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell | Phase III | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Trea | Phase III | rekrutiert |
| BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strateg | ohne Phasenangabe | rekrutiert |
| CORONA in the Saarland | — | rekrutiert |
| Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer | Phase II | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer | ohne Phasenangabe | rekrutiert |
| Digital Solutions for bEtter cAre | ohne Phasenangabe | rekrutiert |
| Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI | ohne Phasenangabe | rekrutiert |
| Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligom | Phase II | rekrutiert |
| EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagl | Phase III | rekrutiert |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in Peop | Phase III | rekrutiert |
| Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With | Phase III | rekrutiert |
| Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With | Phase II | rekrutiert |
| Fracture Monitor - Femur | ohne Phasenangabe | rekrutiert |
| GMMG Multiple Myeloma Registry | — | rekrutiert |
| German Cardiac Arrest Registry | — | rekrutiert |
| German Dementia Registry | — | rekrutiert |
| Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children a | — | rekrutiert |
| Global Research Initiative for Patients Screening on MASH | — | rekrutiert |
| Global SYMPLICITY Registry (GSR) DEFINE | — | rekrutiert |
| Homburg Renal Evaluation Study on the Clinical Utility of Early AKI Diagnosis | — | rekrutiert |
| Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multi | Phase III | rekrutiert |
| Interdisciplinary + Intersectoral Telemedicine Evaluation, Coordination + Treatment in RhineMain | ohne Phasenangabe | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Cal | Phase III | rekrutiert |
| LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MAS | Phase III | rekrutiert |
| Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Curr | Phase III | rekrutiert |
| Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and | Phase III | rekrutiert |
| NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometr | — | rekrutiert |
| Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis | — | rekrutiert |
| Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects | Phase III | rekrutiert |
| PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced N | Phase II | rekrutiert |
| Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combinat | Phase III | rekrutiert |
| Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With New | Phase III | rekrutiert |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - POR | Phase III | rekrutiert |
| Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [Cross | ohne Phasenangabe | rekrutiert |
| Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed C | — | rekrutiert |
| Randomised Evaluation of Sodium Dialysate Levels on Vascular Events | Phase IV | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD- | Phase III | rekrutiert |
| Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study | — | rekrutiert |
| Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Pro | — | rekrutiert |
| Research for Pathophysiology of Cancer Related Fatigue (CRF) and Chronic Fatigue (CFS/ME) | ohne Phasenangabe | rekrutiert |
| Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS) | Phase II | rekrutiert |
| SPYRAL GEMINI Pilot Study | ohne Phasenangabe | rekrutiert |
| Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral | Phase IV | rekrutiert |
| Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Cl | — | rekrutiert |
| Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis | Phase III | rekrutiert |
| Sex diffErences in prehoSpitAl Stroke MEdicine | — | rekrutiert |
| Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With U | ohne Phasenangabe | rekrutiert |
| Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced | Phase III | rekrutiert |
| Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Folli | Phase III | rekrutiert |
| Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Croh | Phase II | rekrutiert |
| Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenou | Phase II | rekrutiert |
| THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for t | ohne Phasenangabe | rekrutiert |
| The "Global Paradise System" Registry | — | rekrutiert |
| The German Keratoplasty Registry of the German Ophthalmological Society (DOG) | — | rekrutiert |
| The Homburg Keratoconus Center (HKC) | — | rekrutiert |
| The K-Map Study, Global Prevalence of KC | — | rekrutiert |
| Time-restricted Feeding in MASLD | ohne Phasenangabe | rekrutiert |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM AL | Phase III | rekrutiert |
| Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Seco | Phase III | rekrutiert |